the resident’s guide to pain management elizabeth kvale, md palliative medicine the american...
Post on 01-Apr-2015
219 Views
Preview:
TRANSCRIPT
THE RESIDENT’S GUIDE TO PAIN MANAGEMENT
Elizabeth Kvale, MDPalliative Medicine
THE AMERICAN GERIATRICS SOCIETY
Geriatrics Health Professionals.
Leading change. Improving care for older adults.
AGS
PAIN PHYSIOLOGY BASICS:TYPES OF PAIN
• Nociceptive — arthritis, fracture, laceration
• Visceral — pancreatitis, MI, constipation
• Neuropathic — herpes zoster, diabetic neuropathy
• Complex regional pain syndromes (RSD)
• Central pain
Slide 2
PAIN PHYSIOLOGY BASICS:ACUTE VS. CHRONIC PAIN
Acute pain• Identified event, resolves
in days–weeks• Usually nociceptive
Chronic pain• Cause often not easily
identified; multifactorial• Indeterminate duration• Nociceptive and/or
neuropathic
Slide 3
PAIN ASSESSMENT BASICS:BELIEVE THE PATIENT
• Pain is a subjective experience ― the patient is the best source of information about their pain
• Pain history ― site(s), intensity, temporality, character, exacerbating and alleviating factors
Slide 4
PAIN ASSESSMENT BASICS:USE AN ASSESSMENT INSTRUMENT
Allows you to know and document whether you have helped the patient
Slide 5
Match the medication to the amount of the patient’s discomfort
PAIN MANAGEMENT BASICS:
Slide 6
ASA
Acetaminophen
NSAIDs
± Adjuvants
1 Mild
A/Codeine
A/Hydrocodone
A/Oxycodone
A/Dihydrocodeine
Tramadol
± Adjuvants
2 Moderate
3 Severe
Morphine
Hydromorphone
Methadone
Levorphanol
Fentanyl
Oxycodone
± Adjuvants
• Don’t delay for investigations or disease treatment
• Unmanaged pain nervous system changesPermanent damageAmplification of pain
• Treat underlying cause (eg, radiation for a neoplasm)
PAIN MANAGEMENT BASICS
Slide 7
• Conjugated in liver
• Excreted via kidney (90%–95%)
• First-order kinetics
• Time to Cmax
PO dosing ― 1 hourSC or IM dosing ― 30 minutes IV dosing ― 6 minutes
PAIN MANAGEMENT BASICS:OPIOID PHARMACOLOGY (1 of 2)
Slide 8
• Steady state after 4–5 half-livesSteady state after 1 day (24 hours)
• Duration of effect of “immediate-release” formulations (except methadone)
3–5 hours PO or PRShorter with parenteral bolus
PAIN MANAGEMENT BASICS:OPIOID PHARMACOLOGY (2 of 2)
Slide 9
Codeine, hydrocodone, morphine, hydromorphone, oxycodone
• Dose q4h
• Adjust dose daily
• Mild or moderate pain: ↑ 25%–50%
• Severe or uncontrolled pain: ↑ 50%–100%
• Adjust more quickly for severe uncontrolled pain
PAIN MANAGEMENT BASICSOral dosing of immediate-release preparations
Slide 10
• Improve compliance, adherence
• Dose q8h, q12h, or q24h (product-specific)Don’t crush or chew tabletsMay flush time-release granules down feeding tubes
• Adjust dose q2–4 days (once steady state reached)
PAIN MANAGEMENT BASICSOral dosing of extended-release preparations
Slide 11
• Use immediate-release opioids5%–15% of 24-h doseOffer after Cmax reached
• PO or PR: ~ q1h• SC or IM: ~ q30min• IV: ~ q10–15min
• Do not use extended-release opioids
PAIN MANAGEMENT BASICSBreakthrough pain
Slide 12
• Ongoing assessment
• Increase analgesics until pain is relieved or adverse effects are unacceptable
• Be prepared for sudden changes in pain
• Driving is safe if pain is controlled, dose is stable, no adverse effects
PAIN MANAGEMENT BASICS
Slide 13
If dose escalation adverse effects:
• Use more sophisticated therapy to counteract adverse effect
• Use an alternative: Route of administration Opioid (“opioid rotation”)
• Use a co-analgesic
• Use a nonpharmacologic approach
CONCERNS ABOUT OPIOID USE:POOR RESPONSE
Slide 14
• Conjugated in liver
• 90%–95% excreted in urine
• If dehydration, renal failure, severe hepatic failure develops: dosing interval, dosage size
• If oliguria or anuria develops: Stop routine dosing of morphine Use only PRN
CONCERNS ABOUT OPIOID USE:CLEARANCE
Slide 15
• Reduced effectiveness to a given dose over time
• Not clinically significant with chronic dosing
• If dose requirement is increasing, suspect disease progression
CONCERNS ABOUT OPIOID USE: TOLERANCE
Slide 16
• Psychological dependence
• Compulsive use
• Loss of control over drugs
• Loss of interest in pleasurable activities
CONCERNS ABOUT OPIOID USE:ADDICTION
Slide 17
• A process of neuroadaptation
• Abrupt withdrawal may abstinence syndrome
• If dose reduction required, reduce by 50%q2–3 days
Avoid antagonists
CONCERNS ABOUT OPIOID USE:PHYSICAL DEPENDENCE
Slide 18
• Can have pain too
• Treat with compassion
• Protocols, contracting
• Consult with pain or addiction specialists
CONCERNS ABOUT OPIOID USE:SUBSTANCE ABUSERS
Slide 19
• Meperidine — accumulates toxic metabolite normeperidine
• Mixed agonists/antagonists – Nubain, Talwin
• Do not use naloxone (Narcan) unless true respiratory crisis (RR < 6)
CONCERNS ABOUT OPIOID USE:THINGS TO AVOID
Slide 20
• Ask the patient Palliative medicine corollary ― believe the patient
• Match the pain medicine to patient’s level of pain
• Increase pain medicine (with awareness ofCmax and half-life) until patient is comfortable
SUMMARY: BASIC PRINCIPLESOF PAIN MANAGEMENT
Slide 21
• Very pleasant 68-year-old admitted with COPD exacerbation
• Home meds include 2 tablets of oxycodone5 mg/APAP “whenever my back acts up” — usually 4 tablets a day
• Appropriate pain medication order?
MRS PAINE
Slide 22
• Readmitted months later with stage IV non-small cell lung cancer
• Taking 2 oxycodone/APAP tabs every 6 hours
• Rates her pain as 7/10 “most of the time”
MRS PAINE
Slide 23
• Maximum acetaminophen dose in 24 hours is 4 grams Tylenol #3 (codeine 30 mg/APAP 325 mg) 24-hr maximum
= 12 tablets Percocet (oxycodone 5 mg/APAP 325 mg) 24-hr maximum =
12 tablets Tylox (oxycodone 5 mg/APAP 500 mg) 24-hr maximum
= 8 tablets Lortab 5 (hydrocodone 5 mg/APAP 500 mg) 24-hr maximum
= 8 tablets
• How long does it take to get a PRN dose of pain medication once it is requested?
KEY POINTS
Slide 24
• Mrs Paine’s total daily oxycodone dose is40 mg (8 tablets 5 mg)
KEY POINTS
Slide 25
Visit us at:
Facebook.com/AmericanGeriatricsSociety
Twitter.com/AmerGeriatrics
www.americangeriatrics.org
THANK YOU FOR YOUR TIME!
linkedin.com/company/american-geriatrics-society
Slide 26
top related